H2AX and cancer: Relating hypomethylation to cancer in the context of the H2AX promoter may complement previous observations linking H2AX overexpression and fibroblast immortality [33, 34], and position H2AX overexpression as a putative contributor to STAT5-induced carcinogenesis.